Swiss BioQuant

Executive Summary

Swiss BioQuant is a Swiss-based Contract Research Organization (CRO) founded in 2008, specializing in regulated bioanalysis services for pharmaceutical and biotechnology clients. The company offers LC-MS/MS and ligand-binding assays for both small and large molecules, supporting non-clinical and clinical studies under GLP and 21 CFR Part 11 compliance. With a strong reputation for quality and reliability, Swiss BioQuant serves as a strategic partner for drug development programs, providing essential bioanalytical data to support regulatory submissions. The company's long-standing presence in Zurich and focus on high-quality, compliant services position it well within the competitive CRO landscape.

Upcoming Catalysts (preview)

• Q2 2027Expansion of laboratory capacity and service offerings65% success
• Q4 2026Strategic partnership with a mid-sized pharmaceutical company50% success